Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bio-Rad Laboratories Inc
BIOCurrent price
293.85 USD
-1.88 USD (-0.64%)
Last closed
295.73 USD
Company
www.bio-rad.com
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Capitalization
8 033 390 592 USD
Yield for 12 month
-24.10 %
1Y
3Y
5Y
10Y
15Y
BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
377.8 USDP/E ratio
–Dividend Yield
–Current Year
+2 671 262 000 USD
Last Year
+2 802 249 000 USD
Current Quarter
+610 820 000 USD
Last Quarter
+681 184 000 USD
Current Year
+1 431 346 000 USD
Last Year
+1 567 330 000 USD
Current Quarter
+326 466 000 USD
Last Quarter
+365 900 000 USD
Key Figures BIO
1 year
3 years
5 years
10 years
EBITDA
502 991 008 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
1.69 %
PEG Ratio
1.1905
Return On Equity TTM
-3.43 %
Wall Street Target Price
377.8 USD
Revenue TTM
2 605 238 016 USD
Book Value
317.32 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-9.8 %
Dividend Yield
–
Gross Profit TTM
1 568 430 000 USD
Earnings per share
-10.69 USD
Diluted Eps TTM
-10.69 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
479.7 %
Profit Margin
-12.37 %
Dividend Analytics BIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
08.03.2002
Dividend Date
–
Stock Valuation BIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
26.9542
Enterprise Value Revenue
3.2048
Price Sales TTM
3.2803
Enterprise Value EBITDA
-13.0746
Price Book MRQ
0.9802
Financials BIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BIO
For 52 weeks
261.59 USD
431.79 USD
50 Day MA
312.92 USD
Shares Short Prior Month
564 754
200 Day MA
331.19 USD
Short Ratio
3.47
Shares Short
733 047
Short Percent
4.1 %
Dynamics of changes in the value of assets
ETF funds
S
BeatStart